~-adrenergic blocking and hemodynamic properties of 5-(3-tert-butyl amino-2-hydroxy) propoxy-3, 4-dihydrocarbostyril hydrochloride (OPC-1085) were investigated and compared with those of propranolol and pindolol on myocardial contractile force, heart rate and arterial blood pressure in pentobarbital anesthetized dogs. OPC-1085 showed almost the same ~-adrenergic blocking potency as pindolol, but was approximately 30 and 20 times stronger than propranolol against isopro terenol and cardiac nerve stimulation, respectively. Slight negative inotropic and chronotropic responses were observed with OPC-1085 in effective blocking doses from 1 to 10 pg/kg but were converted to positive ones in doses from 30 to 30001ppg/kg in non-reserpinized dogs. In reserpinized dogs, both OPC-1085 and pindolol in duced only positive responses. These responses were more evident with OPC-1085.
adrenergic blocking agents have been synthetized.
Among them, propranolol was first introduced in clinical medicine (2) and is now widely prescribed for ischemic heart diseases, hyperkinetic syndrome, cardiac arrhythmias, hypertension etc, although propranolol has a well-known myocardial depressant effect (3, 4) . Pindolol (5, 6, 7) and Ko 1366 (8, 9, 10) have been reported as more potent 3-adrenergic blocking agents which have practically no depressant effect.
Nakagawa et al. (11) described antagonistic action of a series of dihydrocarbostyril derivatives against isoproterenol, among which 5-(3-tert-butylamino-2-hydroxy) propoxy 3, 4-dihydrocarbostyril hydrochloride (OPC-1085) was the most promising compound because of its potent effect with duration of action as long as that of pindolol. In this study, we investigated the f-adrenergic blocking properties of OPC-1085 and compared them with those of propranolol and pindolol on cardiovascular responses of the dog.
MATERIALS AND METHODS
Fifty adult mongrel dogs of both sexes, weighing from 10 to 20 kg, were anesthetized with sodium pentobarbital, 30 mg/kg i.v. In forty-five dogs, both vagus nerves had been cut at the mid-cervical level. Intubation was carried out and the tracheal tube was at tached to a respirator. The chest was opened by the mid-line incision and the heart was suspended in the pericardial cradle. The contractile force of the myocardium was mea & D. KINOSHITA sured by means of a Walton-Brodie strain-gauge arch sutured on to the right ventricle. Arterial blood pressure at the femoral artery was recorded by an elect roman ometer and the heart rate by a cardiotachograph which was triggered by R waves of ECG (Lead 11). In fifteen dogs, the right cardiac nerve was stimulated for 30 sec with square-wave pulses;
1 cosec duration, 40 Hz and supramaximal voltage (6-8 V) , and in five dogs, the right vagus nerve for 20 sec with the following stimulus; 1 cosec duration, 2, 5 or 10 Hz and supra maximal voltage (2-5 V).
Drugs used in these experiments were 1-isoproterenol hydrochloride (Nikken Kagaku), dl-epinephrine hydrochloride, dl-norepinephrine hydrochloride (Sankyo) and calcium chloride as agonists, while propranolol hydrochloride (ICI), pindolol (LB-46, Sankyo) and 5-(3-tert-butylamino-2-hydroxy) propoxy-3, 4-dihydrocarbostyril hydrochloride (OPC 1085, Otsuka) as antagonists and reserpine (Ciba). All drugs were dissolved in 0.9 saline except for pindolol which was dissolved in 0.9% saline with equimolar maleic acid.
The injected volume was 0.1 ml/kg which was administered through a catheter into the femoral vein in a period of 1 min. The i.v. administration of agonists and nerve stimu lation were performed 10 min after each injection of f3-adrenergic blocking agent in cu mulative doses of 1, 3, 10, 30, 100, 300 and 1000,cag/kg at 20 min-intervals. The ED50 for blocking cardiovascular responses to isoproterenol and right cardiac nerve stimulation was estimated from straight lines obtained by plotting the inhibition in percent against a logarithmic dose.
Thirty dogs were used to investigate the direct actions of OPC-1085, pindolol and propranolol on the cardiovascular system, fifteen dogs of which were pretreated with re serpine for 2 days, 0.5 mg/kg followed by 1 mg/kg s.c. Myocardial contractile force, heart rate and arterial blood pressure were measured in a similar way for reserpinized dogs but with less anesthetic doses of sodium pentobarbital (20 mg/kg i.v.). These Q-adre nergic blocking agents were injected intravenously in cumulative doses from 1 ,ug/kg to 10 mg/kg at 5 min-intervals and the cardiovascular parameters were determined 5 min after administration of each dose. and a marked hypotension which lasted from 2 to 8 min (Fig. 1 ). These cardiovas cular responses to isoproterenol as an agonist were dose-dependently depressed by OPC 1085, pindolol and propranolol in a dose range from 1 to 30 /,tg/kg for the former two and from 10 to 300 1 g/kg i.v. for the latter one. OPC-1085, 30 /.Ig/kg, completely in hibited these responses to isoproterenol but not completely with 30 ,ng/kg of pindolol or 300 /,t-/kg of propranolol ( Fig. 1 ). The ED50 of OPC-1085, pindolol and propranolol as antagonists is tabulated in Table 1 and was found to be almost the same between OPC-1085 and pindolol, i.e., approximately 30 times more potent than propranolol. I to 100 1tg/kg for the former two and 10 to 1000 /tg/kg i.v. for the latter one. The dose response curves of inhibitory effects of OPC-1085, pindolol and propranolol are parallel as shown in Fig. 2 . The ED50 of these drugs is tabulated in Table 2 (Fig. 4) . (Fig. 6 ).
RESULTS
In fifteen reserpinized dogs, the control values of heart rate and mean systemic blood pressure were 10V _3.0 beats/min (mean 1SE) and 7512.5 mmHg (mean _1_SE), re spectively. These values were obviously lower than those observed in non-treated dogs.
OPC-1085 and pindolol induced positive inotropic and chronotropic responses even with the smallest dose of I lag/kg i.v. used in this study, but OPC-1085 was more potent than pindolol. On the other hand, propranolol produced negative inotropic and chronotropic effects with 30 and 300pg/kg i.v., respectively. These cilects were always significantly weaker in reserpinized dogs (Fig. 7) . dose response curves of OPC-1085, pindolol and propranolol suggest that OPC-1085 has similar /-adrenergic blocking properties to pindolol and propranolol. Cheymol et al. (9) reported that Kip 1366, one of f3-adrenergic blocking agents, depressed the effects of nerve stimulation more than the effects of isoproterenol, and thus they suggested an inhibition of norepinephrine release by Kb 1366. The present study shows no such effect of OPC-1085. OPC-1085 inhibited the positive inotropic and chronotropic responses to epinephrine and norepinephrine. It potentiated the pressor response to epinephrine, but not to nor epinephrine. In 1966, Shanks (3) reported that propranolol blocked the vasodilator re sponse to epinephrine and potentiated the pressor response to epinephrine. In this study, it appeared that the potentiation of the pressor response to epinephrine by OPC-1085 was due to a block of the peripheral vasodilator action of epinephrine without affecting its vasoconstrictor action such as was seen with propranolol.
Furthermore in the present experiments, OPC-1085 was proven to be a specific fl-adre nergic blocking agent as it has no effect on the positive inotropic response induced by CaCI2, bradycardia to vagal nerve stimulation and pressor response to norepinephrine.
OPC-1085 and pindolol showed definite positive inotropic and chronotropic responses in reserpinized dogs, while slight negative ones in non-treated animals in a range from 1 to 30 It-/kg i.v. which is the effective dose as a fl-adrenergic blocking agent. These obser vations indicate the existence of a prevailing sympathetic tone in dogs anesthetized with sodium pentobarbital. These positive inotropic and chronotropic effects were more prominent in reserpinized dogs. Thus we conclude that OPC-1085 has a sympathomime tic action which is well known with alprenolol (18, 19) , Ko 1366 (10) and dichloroisopro terenol (20) . Hashimoto et al. (21) and Ohkuda et al. (22) have observed that an intra arterial injection of a smaller dose of dichloroisoproterenol, pindolol, alprenolol or pra ctolol produced a positive chronotropic response in the in situ sino-atrial node prepara tion which is the same as was seen with Kb 1366, pindolol or practolol in the isolated blo od-perfused one (23) . OPC-1085 induced a more prominent sympathomimetic effect with cumulative administration of increasing doses than did pindolol. Negative inotropic and chronotropic responses were never induced with any dose of OPC-1085 but such responses were evident with pindolol in very large doses. The negative inotropic and chronotropic responses to pindolol were significantly weaker than those of propranolol which is in agreement with previous reports (5, 6, 7) .
From these studies, it is concluded that OPC-1085 is one of the most potent fl-ad renergic blocking agents devoid of negative inotropic and chronotropic actions with sym pathomimetic effects. Furthermore, it was demonstrated that OPC-1085 has a weaker hypotensive action than that of pindolol or propranolol.
